Biomarkers in Psychiatric Disorders

Central and peripheral biomarkers can be used to diagnose, treat, and potentially prevent major psychiatric disorders. But there is uncertainty about the role of these biological signatures in neural pathophysiology, and their clinical significance has yet to be firmly established. Psychomotor, cogn...

Full description

Saved in:  
Bibliographic Details
Main Author: Glannon, Walter (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: Cambridge Univ. Press 2022
In: Cambridge quarterly of healthcare ethics
Year: 2022, Volume: 31, Issue: 4, Pages: 444-452
Further subjects:B Prevention
B Treatment
B biomarkers
B Prediction
B Schizophrenia
B Diagnosis
B Psychiatry
B Major Depressive Disorder
Online Access: Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000naa a22000002 4500
001 1827982527
003 DE-627
005 20221220052655.0
007 cr uuu---uuuuu
008 221220s2022 xx |||||o 00| ||eng c
024 7 |a 10.1017/S0963180122000056  |2 doi 
035 |a (DE-627)1827982527 
035 |a (DE-599)KXP1827982527 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Glannon, Walter  |e VerfasserIn  |4 aut 
245 1 0 |a Biomarkers in Psychiatric Disorders 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Central and peripheral biomarkers can be used to diagnose, treat, and potentially prevent major psychiatric disorders. But there is uncertainty about the role of these biological signatures in neural pathophysiology, and their clinical significance has yet to be firmly established. Psychomotor, cognitive, affective, and volitional impairment in these disorders results from the interaction between neural, immune, endocrine, and enteric systems, which in turn are influenced by a person’s interaction with the environment. Biomarkers may be a critical component of this process. The identification and interpretation of biomarkers also raise ethical and social questions. This article analyzes and discusses these aspects of biomarkers and how advances in biomarker research could contribute to personalized psychiatry that could prevent or mitigate the effects of these disorders. 
601 |a Psychiatrie 
650 4 |a Treatment 
650 4 |a Schizophrenia 
650 4 |a Psychiatry 
650 4 |a Prevention 
650 4 |a Prediction 
650 4 |a Major Depressive Disorder 
650 4 |a Diagnosis 
650 4 |a biomarkers 
773 0 8 |i Enthalten in  |t Cambridge quarterly of healthcare ethics  |d Cambridge : Cambridge Univ. Press, 1992  |g 31(2022), 4, Seite 444-452  |h Online-Ressource  |w (DE-627)306655039  |w (DE-600)1499985-7  |w (DE-576)081985010  |x 1469-2147  |7 nnns 
773 1 8 |g volume:31  |g year:2022  |g number:4  |g pages:444-452 
856 4 0 |u https://doi.org/10.1017/S0963180122000056  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.cambridge.org/core/journals/cambridge-quarterly-of-healthcare-ethics/article/biomarkers-in-psychiatric-disorders/D10686D6D08A5ECA03288CD34B38553D  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
936 u w |d 31  |j 2022  |e 4  |h 444-452 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 423538743X 
LOK |0 003 DE-627 
LOK |0 004 1827982527 
LOK |0 005 20221220052655 
LOK |0 008 221220||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-12-06#F0BAF712FCFCF448F6D11CC044FDCDBB314F7054 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw